510(k) Report

FDA applicant

Augmenix, Inc.

Waltham, MA5 decisions2013–20192 recalls

FDA records 5 decisions for Augmenix, Inc. (Waltham, MA) from 2013 to 2019: 4 510(k) clearances and 1 De Novo grant. Most are in product codes OVB (Hydrogel Spacer) and NEU (Marker, Radiographic, Implantable). Its devices cite 5 predicates, 3 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, radiology panel, where it files most

How often FDA has decided Augmenix, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2019

2013: 12015: 22018: 12019: 1
2013high 2 (2015) · low 0 (2014)2026

2026 so far, outlined.

Recalls per year

2in 2022

2022: 2
2013high 2 (2022) · low 0 (2013)2026

Class I Class II/III not classified

FIG. 1 — Augmenix, Inc. by year, 2013–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Augmenix, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report